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Introduction 
The use of phenotypically matched sets of homolo- 
gous R sub(1)R sub(1), R sub(2)R sub(2), and rr red blood cells (RBCs) to ad- 
sorb warm autoantibodies permits identification of un- 
derlying alloantibodies.' This case report describes the 
use of a set of homologous RBCs to perform serum ad- 
sorptions and corresponding elutions, to separate and 
identify anti-E, -P sub(1), -N, jk sup(a), -K, -S, Fy sup(b), -Do sup(a), -Kp sup(a), -Lu sup(a), 
and -V/VS in a patient's serum. 
Case Report 
A 66-year-old Caucasian female was admitted to a 
hospital suffering from intestinal obstruction due to 
adenocarcinoma of the colon. At the time of admission, 
the antibody screen and autocontrol were negative, 
and two crossmatch-compatible units of blood were 
transfused. Two weeks posttransfusion, the hemo- 
globin fell and the antibody screen became positive; 
however, the direct antiglobulin test remained nega- 
tive, suggesting rapid clearance of transfused red cells. 
The patient's hemoglobin was 8 g/dL, and one unit of 
blood was requested for transfusion. A sample of blood 
from the patient was sent to a reference laboratory for 
antibody identification. 
Materials and Methods 
Adsorptions and Elutions 
R sub(1)r, Do(a-), M+N-, Psup(1)-, Le(a-b-), S - s + ,  
K-  k+ , Fy(a+ b+ ), Jk(a+ b -) RBCs, R sub(2)R sup(2), Do(a+ ), 
M + N - ,  P sub(1)+, Le(a-b+), S + s + ,  K-k+,  
Fy(a-b+), Jk(a+b+) RBCs and rr, Do(a-), 
M + N - ,  P sub(1)-, Le(a+b-), S + s + ,  K-k+,  
Fy(a+ b + ), Jk(a - b + ) RBCs, collected in EDTA, were 
obtained from laboratory staff. The red cells used for 
absorption were not enzyme treated prior to use be- 
cause of difficulty in harvesting antibody from treated 
RBCs. Three successive adsorptions with homologous 
RBCs were performed at 37" for 60 min using equal 
volumes of serum and RBCS. sup(2) The serum was neutra- 
lized with P sub(1) substance (Ortho Diagnostics, Inc., Ra- 
ritan, NJ). Eluates from the absorbing cells were pre- 
pared using reagent grade diethyl ether (Mallinckrodt, 
Inc., Paris, 
Serum and Eluate Testing 
The adsorbed serum was tested either by the stan- 
dard tube method converted to the indirect anti- 
globulin test (IAT) or by the direct4 and indirect5 capil- 
lary techniques, depending upon the amount of serum 
remaining following adsorption. LISS (American Red 
Cross, Bethesda, MD), ficin (Sigma Co., St. Louis), and 
papain solutions (Cooper Biomedical, Malvern, PA) 
were used to potentiate serum reactions and to dena- 
ture the N, S, and Fy sup(a) antigens on reagent red cells. 
Ether eluates were tested by the standard tube-TAT 
method. The reagent red cells used for testing both 
serum and eluates were obtained from several com- 
mercial sources. 
Red Cell Phenotyping 
Commercial antisera and serum from patients and 
donors containing well-defined antibodies were used, 
with appropriate controls, to phenotype both the pa- 
tient's RBCs and commercial RBCs. 
Serum Titrations 
The neat serum was titrated, using serial two-fold di- 
lutions, in saline and in pooled sera,' and tested against 
a reactive phenotypically similar RBC [rr, K- ,  
Fy(b-), Jk(a-), S-, Lu(a-), P sub(1)-, k(a-b-)] ,  as an 
initial step in determining whether the serum con- 
tained a high-titer, lowavidity (HTLA) antibody. 
Results 
The patient's red cells typed as group AB, Rh- 
positive, and the DAT on both pre- and posttransfusion 
red cells was negative. A phenotype done on pretrans- 
fusion red cells was as follows: C + E - c + e + ,  
M + N - S - s + ,  K-,  Js(b+), Fy(a+b-),Jk(a-b+), 
k(a-b-),  Psub(1)-, PPsub(1)Psup(k)+, Do(a+), Xg(a+), Vel+, 
Lu(b+) and Yt(a+). 
An initial panel of selected reagent red cells, based 
on the patient's common antigen phenotype, detected 
antip-P sub(1), and -N at room temperature and anti-Fy sup(b) in 
LISS-IAT. Following identification of anti-P sub(1), all addi- 
tional testing was done using P sub(1) neutralized serum. 
After serum inhibition, anti-E could be identified by en- 
zyme capillary-IAT, but some cells negative for N, Fy sup(b), 
and E continued to react. 
Homologous adsorption-elutions were necessary to 
separate the remaining multiple antibodies. Table 1 
shows the results of adsorption-elution tests. Serum ad- 
sorbed with the R sub(1),r RBCs defined anti-Do", -E, -N, -S, -K, 
-V/VS, and -Lu sup(2). Serum adsorbed with R sub(2)R sub(2) RBCs con- 
firmed the presence of anti-Do", -N, -K, -V/VS, -Lu sup(a), and 
identified anti-Kp sup(a), Serum adsorbed with rr RBCs con- 
firmed anti-Do sup(2), -E, -N, -K and identified anti-Jk sup(a). The rr 
adsorbed serum was not tested for anti-Lu sup(a) and -V/VS. 
Anti-Fy sup(b) and -Jk were confirmed by elution from the 
Rlr RBCs. 
Discussion 
Anti-Dos is not considered an HTLA antibody. The 
failure of the R sub(2)R sub(2), Do(a + b - ) RBCs to completely re- 
move anti-Doa from the serum, however, was not an 
unexpected finding (Table l), as it reacted to a titer of 
256 in a manner similar to that seen with HTLA anti- 
bodies, which are difficult to adsorb and elute.' 
Using neat serum and serum neutralized with PI 
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substance, combined with adsorption-elution proce- 
dures, the 11 antibodies in this patient's serum were 
separated and identified. The use of a matched set of 
homologous absorbing cells was invaluable in identi- 
fying seven of the antibodies (anti-K, -Jk sup(a), -S, -Do", -Kp sup(a), 
-Lu sup(a), -V/VS) and should be considered for resolution of 
complex antibody problems when reagent red cells of 
the appropriate antigen profile are not available. 
A complete phenotype of the patient's red cells is 
necessary when resolving complex mixtures of alloan- 
tibodies as documented by this study, as it enables se- 
lection of the most advantageous reagent panel cells for 
exclusion of antibodies the patient can form. In addi- 
tion, antigen typings such as Xg sup(a), Do", Do sup(b), Lu sup(a), Kp sup(a), Js sup(a), 
and V/VS, listed on some red cell antigenic profiles, 
provide an opportunity to identify more unusual anti- 
bodies in suitably adsorbed serums of patients who 
have produced multiple common antibodies. 
Table 1. Antibodies identified in the adsorbed (P sub(1) neu- 
tralized) sera and corresponding eluates 
Absorbing RBCs Adsorbed serum Corresponding eluate 
R sub(1)r, Do(a- )  Anti-Do sup(a),-E,-N,-S, Anti-Fy sup(b);Jk sup(a) 
-K;-V/VS;-Lu sup(a) 
R sub(2)R sub(2), Do(a+ b - )  Anti-Do sup(a),-Kp sup(a),-Lu sup(a), Not tested 
-V/VS,-N;K 
rr, Do(a - ) Anti-Do sup(a),-E,-N, Not tested 
-Jk sup(a), -K 
References 
1. Wallhermfechtel MA, Pohl BA, Chaplin H. Alloimmunization in 
patients with warm autoantibodies. Transfusion 1984;24:482-5. 
2. Widmann FK, ed. Technical manual. 9th ed. Arlington, VA: 
American Association of Blood Banks, 1985430-1, 224. 
3. Rubin H. Antibody elution from red blood cells. J Clin Pathol 
1963;16:70-2. 
4. Crawford MN. Rapid testing of ficinized cells in capillary tube. 
Transfusion 19 7 8  18:598. 
5. Graves 8. Application of the antiglobulin phase to capillary tube 
testing. Transfusion 1981;21:373. 
6. Rolih SD, ed. Recognition and resolution of high-titer, low- 
avidity antibodies. Washington, DC: American Association of 
Blood Banks, 1979:24. 
Michael Gorman, MT(ASCP)SBB, Jerome H.  Holland Laboratory 
for the Biomedical Sciences, American Red Cross Medical Opera- 
tions, 15601 Crabbs Branch Way, Rockville, MD 20855-2736; 
Susan S. Todoroff MT(ASCP)SBB, and Jeanmarie Celich, 
MT(ASCP)SBB, American Red Cross BIood Services, Northern Ohio 
Region, 3950 Chester Avenue, Cleveland, OH 441 14. 
TECH HINTS 
BATTERY-OPERATED CENTRIFUGE 
Mary N. Crawford 
A battery-operated centrifuge was developed for 
capillary tube test demonstrations in nonlaboratory lo- 
cations. With this small piece of equipment, it is pos- 
sible to spin down red cell suspensions in 2 min using 
Fisher-type plastic 1.0 mL tubes. For about $6, this cen- 
trifuge can be assembled with four “D” batteries, a 
small hobby motor, and a stiff plastic "head with two 
holes for the Fisher tubes. 
A variety of hobby motors is available from Edmund 
Scientific (Barrington, NJ) and from other hobby and 
electronic catalogs. These should be capable of 
achieving 1000-3000 rpm with 1.5 volt “D” batteries 
and preferably should include two wire leads. 
The plastic "head may be cut from a flexible plastic 
box and will need a central hole to fit it onto the motor 
shaft. It will also need two holes to hold the small 
Fisher plastic tubes. Microcentrifuge plastic tubes may 
also be used. The plastic head is held in place with a 
small rubber dropper bulb. These bulbs may be sal- 
vaged from the 3.0 mL vials in BCA's red cell panels 
(Cooper Biomedical, Malvern, PA). Spinning wears 
away the rubber inside the bulb, so spares must be at 
hand. 
The four batteries, with the motor atop, may be 
fitted into a narrow spaghetti or similar box. For safety, 
the whole assembly can be lodged in a larger card- 
board box and covered with window screening. The 
box sides must be low enough for the spinning tubes. 
One of the motor wires can be permanently attached 
with tape to either end of the battery pack, and the "on 
and off" wire can he bound to a small magnet attached 
to a wooden applicator stick. To turn the motor on or 
off, the stick, which is supported by a hole in the 
screening, can be easily moved so that the attached 
wire makes contact with the metal end of the fourth 
battery. 
This simple device can be used in hotel rooms, in the 
field, or as an emergency centrifuge during electrical 
failures. It may, however, be hard to explain to airport 
security personnel! 
Mayr N. Crawford MD, Pearson C Cummin Memorial Laboratory, 
125 Ashwood Road Villanova. PA 19085. 
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